Open Mobile Menu
2023 Cancer and Blood Diseases Institute Accomplishments Report
Contact Us
Close Mobile Menu
Overview
Accomplishments
After the World’s First FLASH Proton Therapy Clinical Trial Shows Promise, a Second Trial is Underway
Novel Natural Killer Cell Therapy is the Focus of a New Clinical Study for Adolescents and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia
Novel Cell Therapy Strategy Achieves Telomere Elongation in Clinical Trial, a Potential Breakthrough in the Treatment of Telomere Biology Disorders
Cincinnati Children’s Infuses Its First Two Patients with Newly Approved Beta Thalassemia Gene Therapy
Meet Our Team
Program Data
Facebook
Twitter
Email
Program Data
Overall FY23 Data (July 2022-June 2023)
